Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DNM1 | Q05193 | 7/20 | 0.48 |
| ▸ | CA12 | O43570 | 1/20 | 0.43 |
| ▸ | CA1 | P00915 | 1/20 | 0.43 |
| ▸ | CA2 | P00918 | 1/20 | 0.43 |
| ▸ | CA9 | Q16790 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 4/20 | 0.42 |
| ▸ | THRB | P10828 | 1/20 | 0.42 |
| ▸ | MGLL | Q99685 | 1/20 | 0.39 |
| ▸ | ADH1C | P00326 | 1/20 | 0.38 |
| ▸ | ADH1A | P07327 | 1/20 | 0.38 |
| ▸ | ADH4 | P08319 | 1/20 | 0.38 |
| ▸ | HTT | P42858 | 1/20 | 0.36 |
| ▸ | GBA1 | P04062 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4602011 | 1.00 | DNM1 (0.48) | DNM1CA12CA1CA2CA9 | |
| SCHEMBL271649 | 1.00 | DNM1 (0.48) | DNM1CA12CA1CA2CA9 | |
| SCHEMBL271233 | 0.97 | DNM1 (0.46) | DNM1CA12CA1CA2CA9 | |
| SCHEMBL270639 | 0.97 | DNM1 (0.43) | DNM1CA12CA1CA2CA9 | |
| SCHEMBL269626 | 0.95 | DNM1 (0.44) | DNM1CA12CA1CA2CA9 | |
| SCHEMBL269573 | 0.95 | DNM1 (0.42) | DNM1CA12CA1CA2CA9 | |
| SCHEMBL270747 | 0.92 | DNM1 (0.40) | DNM1CA12CA1CA2CA9 | |
| SCHEMBL271652 | 0.90 | DNM1 (0.44) | DNM1CA12CA1CA2CA9 | |
| SCHEMBL269464 | 0.89 | ALDH1A1 (0.37) | DNM1CA12CA1CA2CA9 | |
| SCHEMBL269999 | 0.87 | DNM1 (0.40) | DNM1CA12CA1CA2CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 86 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1697309-B1 | BENZOYL-SUBSTITUTED PHENYLALANINE AMIDES | BASF SE (DE) | 2014-04-23 | — | — | EP | disclosed |
| EP-1888509-B1 | BENZOYL-SUBSTITUTED SERINE AMIDES | BASF SE (DE) | 2013-05-15 | — | — | EP | disclosed |
| US-8133851-B2 | Heteroaroyl-substituted serine amides | BASF SE (DE) | 2012-03-13 | — | — | US | disclosed |
| US-20110318470-A1 | Method For Improving Plant Health | BASF SE (DE) | 2011-12-29 | — | — | US | disclosed |
| US-20110209253-A1 | Method for Improving Plant Health | BASF SE (DE) | 2011-08-25 | — | — | US | disclosed |
| EP-2348841-A1 | METHOD FOR IMPROVING PLANT HEALTH | BASF SE (DE) | 2011-08-03 | — | — | EP | disclosed |
| EP-2348849-A1 | METHOD FOR IMPROVING PLANT HEALTH | BASF SE (DE) | 2011-08-03 | — | — | EP | disclosed |
| US-7879761-B2 | Herbicides; 1-{Methylcarbamoyl-[(1-methyl-3-trifluoromethyl-1H-pyrazol-4-carbonyl)amino]methyl}-allyl acetate; acylation of keto compounds and reduction of the ketone, or the serine derivative is reacted with a heteroaryl acid and then with a secondary or tertiary amine | BASF AKTIENGESELLSCHAFT (DE) | 2011-02-01 | — | — | US | disclosed |
| EP-2121583-B1 | HETEROARYL-SUBSTITUTED SERINE AMIDES | BASF SE (DE) | 2010-09-22 | — | — | EP | disclosed |
| US-7786046-B2 | Benzoyl-substituted serineamides | BASF AKTIENGESELLSCHAFT (DE) | 2010-08-31 | — | — | US | disclosed |
| WO-2000059910-A2 | TRICYCLIC PYRAZOLONE DERIVATIVES | BASF AKTIENGESELLSCHAFT (DE) | 2000-10-12 | — | — | WO | disclosed |
| WO-2000059911-A2 | TRICYCLIC CYCLOHEXANEDIONE DERIVATIVES | BASF AKTIENGESELLSCHAFT (DE) | 2000-10-12 | — | — | WO | disclosed |
| WO-2000055158-A1 | TRICYCLIC BENZOYLPYRAZOLE DERIVATIVES USED AS A HERBICIDE | BASF AKTIENGESELLSCHAFT (DE) | 2000-09-21 | — | — | WO | disclosed |
| WO-2000035903-A2 | THIOCHROMANOYL CYCLOHEXENONE DERIVATIVES | BASF AKTIENGESELLSCHAFT (DE) | 2000-06-22 | — | — | WO | disclosed |
| WO-2000034270-A1 | THIOCHROMANOYLPYRAZOLONE DERIVATIVES | BASF AKTIENGESELLSCHAFT (DE) | 2000-06-15 | — | — | WO | disclosed |
| WO-2000014069-A1 | CYCLOHEXENONQUINOLINOYL-DERIVATIVES AS HERBICIDAL AGENTS | BASF AKTIENGESELLSCHAFT (DE) | 2000-03-16 | — | — | WO | disclosed |
| WO-1999059991-A1 | PYRAZOLYLDIOXOTHIOCHROMANOYL DERIVATIVES | BASF AKTIENGESELLSCHAFT (DE) | 1999-11-25 | — | — | WO | disclosed |
| EP-0958292-A1 | 4-(3-HETEROCYCLYL-1-BENZOYL)PYRAZOLES AND THEIR USE AS HERBICIDES | BASF AKTIENGESELLSCHAFT (DE) | 1999-11-24 | — | — | EP | disclosed |
| WO-1999057111-A1 | CYCLOHEXENONDIOXOTHIO CHROMANOYL DERIVATIVES | BASF AKTIENGESELLSCHAFT (DE) | 1999-11-11 | — | — | WO | disclosed |
| WO-1998031682-A1 | 4-(3-HETEROCYCLYL-1-BENZOYL)PYRAZOLES AND THEIR USE AS HERBICIDES | BASF AKTIENGESELLSCHAFT (DE) | 1998-07-23 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110318470-A1 | Method For Improving Plant Health | BROX, PAH, GUSB | DNM1 1420/4885CA12 4384/4885CA1 4406/4885 |
| US-20110209253-A1 | Method for Improving Plant Health | AADAT, AAAS, GUSB | DNM1 1613/4885CA12 4219/4885CA1 4332/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.